Xuwei Hou

1.2k total citations
38 papers, 980 citations indexed

About

Xuwei Hou is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Xuwei Hou has authored 38 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Cardiology and Cardiovascular Medicine and 9 papers in Surgery. Recurrent topics in Xuwei Hou's work include Apelin-related biomedical research (5 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (4 papers) and Lipid metabolism and disorders (4 papers). Xuwei Hou is often cited by papers focused on Apelin-related biomedical research (5 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (4 papers) and Lipid metabolism and disorders (4 papers). Xuwei Hou collaborates with scholars based in China, United States and Tunisia. Xuwei Hou's co-authors include Jian‐Xiong Chen, Heng Zeng, Xiaochen He, Ningfu Wang, Lanfang Li, Meili Lü, Zhaohui Hu, Xiuying He, Yigang Zhong and Bo Yin and has published in prestigious journals such as Circulation, PLoS ONE and Stroke.

In The Last Decade

Xuwei Hou

38 papers receiving 968 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuwei Hou China 19 355 228 183 181 157 38 980
Alexander J. Glassford United States 8 262 0.7× 246 1.1× 204 1.1× 192 1.1× 95 0.6× 9 989
Yung‐Chien Hsu Taiwan 18 560 1.6× 182 0.8× 89 0.5× 97 0.5× 154 1.0× 41 1.2k
Tamotsu Yokota Japan 21 589 1.7× 184 0.8× 196 1.1× 70 0.4× 127 0.8× 37 1.4k
Bruno Poirier France 20 270 0.8× 379 1.7× 163 0.9× 274 1.5× 256 1.6× 27 1.5k
Ruihai Zhou United States 17 337 0.9× 172 0.8× 133 0.7× 122 0.7× 59 0.4× 40 904
Federico Biscetti Italy 26 580 1.6× 447 2.0× 230 1.3× 93 0.5× 149 0.9× 66 1.5k
Xiaochen He United States 19 420 1.2× 197 0.9× 299 1.6× 167 0.9× 134 0.9× 41 1.2k
Jinchuan Yan China 24 555 1.6× 142 0.6× 148 0.8× 60 0.3× 166 1.1× 81 1.5k
Hongyan Dai China 20 451 1.3× 204 0.9× 293 1.6× 113 0.6× 129 0.8× 53 1.1k
Emilie Distel France 12 483 1.4× 257 1.1× 167 0.9× 91 0.5× 398 2.5× 15 1.5k

Countries citing papers authored by Xuwei Hou

Since Specialization
Citations

This map shows the geographic impact of Xuwei Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuwei Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuwei Hou more than expected).

Fields of papers citing papers by Xuwei Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuwei Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuwei Hou. The network helps show where Xuwei Hou may publish in the future.

Co-authorship network of co-authors of Xuwei Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Xuwei Hou. A scholar is included among the top collaborators of Xuwei Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuwei Hou. Xuwei Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lü, Meili, et al.. (2021). Ginsenoside Rg1 attenuates mechanical stress-induced cardiac injury via calcium sensing receptor-related pathway. Journal of Ginseng Research. 45(6). 683–694. 14 indexed citations
2.
3.
Hou, Xuwei, et al.. (2016). Abstract 18317: Activation of Autophagy Mediates Insulin-Like Growth Factor I (igf-1)-Induced Anti-Apoptotic Effect in Vascular Smooth Muscle Cells. Circulation. 1 indexed citations
4.
Hou, Xuwei, et al.. (2015). Apelin Gene Therapy Increases Autophagy via Activation of Sirtuin 3 in Diabetic Heart. PubMed. 1(4). 84–91. 14 indexed citations
5.
Shen, Zhipeng, Xuwei Hou, Qing Chen, Peng Chen, & Qing Zhang. (2015). NOTCH3 Gene Polymorphism is Associated With the Prognosis of Gliomas in Chinese Patients. Medicine. 94(9). e482–e482. 10 indexed citations
6.
7.
Mei, Meng, Futian Tang, Meili Lü, et al.. (2015). Astragaloside IV attenuates apoptosis of hypertrophic cardiomyocyte through inhibiting oxidative stress and calpain-1 activation. Environmental Toxicology and Pharmacology. 40(3). 764–773. 43 indexed citations
8.
Hou, Xuwei, Heng Zeng, Xiaochen He, & Jian‐Xiong Chen. (2014). Sirt3 is essential for apelin‐induced angiogenesis in post‐myocardial infarction of diabetes. Journal of Cellular and Molecular Medicine. 19(1). 53–61. 68 indexed citations
9.
Xu, Xiaolin, Xuwei Hou, Yixiu Liang, et al.. (2014). The Gene Polymorphism of LOX1 Predicts the Incidence of LVH in Patients with Essential Hypertension. Cellular Physiology and Biochemistry. 33(1). 88–96. 13 indexed citations
10.
Shen, Zhipeng, et al.. (2014). Polymorphism -433 C>T of the Osteopontin Gene is Associated with the Susceptibility to Develop Gliomas and their Prognosis in a Chinese Cohort. Cellular Physiology and Biochemistry. 34(4). 1190–1198. 15 indexed citations
11.
Wang, Zhanchao, Xuwei Hou, Jiang Shao, et al.. (2014). HIF-1α Polymorphism in the Susceptibility of Cervical Spondylotic Myelopathy and Its Outcome after Anterior Cervical Corpectomy and Fusion Treatment. PLoS ONE. 9(11). e110862–e110862. 9 indexed citations
12.
Hou, Xuwei, Zhaohui Hu, & Ningfu Wang. (2014). Abstract 195: Simvastatin Rescues Impaired Angiogenesis Potential of Cerebrovascular Endothelial Cells by AGEs : The Role of Autophagy. Stroke. 45(suppl_1). 1 indexed citations
13.
Liang, Yi, Xuwei Hou, Ji Zhou, et al.. (2014). HIF-1α Genetic Variants and Protein Expression Confer the Susceptibility and Prognosis of Gliomas. NeuroMolecular Medicine. 16(3). 578–586. 14 indexed citations
14.
Hou, Xuwei, Zhaohui Hu, Xiaohua Huang, et al.. (2013). Serum osteopontin, but not OPN gene polymorphism, is associated with LVH in essential hypertensive patients. Journal of Molecular Medicine. 92(5). 487–495. 19 indexed citations
15.
Zhang, Shuquan, et al.. (2013). Polymorphisms of Receptor for Advanced Glycation end Products and Risk of Epithelial Ovarian Cancer in Chinese Patients. Cellular Physiology and Biochemistry. 31(4-5). 525–531. 31 indexed citations
16.
Li, Baoxin, Xuwei Hou, Changyu Li, et al.. (2013). OPN Gene Polymorphism and the Serum OPN Levels Confer the Susceptibility and Prognosis of Ischemic Stroke in Chinese Patients. Cellular Physiology and Biochemistry. 32(6). 1798–1807. 16 indexed citations
17.
Zhong, Yigang, et al.. (2012). Ischemia-modified albumin in stable coronary atherosclerotic heart disease. Coronary Artery Disease. 23(8). 538–541. 21 indexed citations
18.
Wang, Yongzheng, Xuwei Hou, & Yuliang Li. (2010). Association between transforming growth factor β1 polymorphisms and atrial fibrillation in essential hypertensive subjects. Journal of Biomedical Science. 17(1). 23–23. 18 indexed citations
19.
Hou, Xuwei, et al.. (2009). Association between transforming growth factor β1 polymorphisms and left ventricle hypertrophy in essential hypertensive subjects. Molecular and Cellular Biochemistry. 335(1-2). 13–17. 19 indexed citations
20.
Hou, Xuwei, Lifang Wang, Ningfu Wang, et al.. (2007). The G501C polymorphism of oxidized LDL receptor gene [OLR-1] is associated with susceptibility and serum C-reactive protein concentration in Chinese essential hypertensives. Clinica Chimica Acta. 388(1-2). 200–203. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander J. Glassford Breakdown of academic impact, for papers by Yung‐Chien Hsu Breakdown of academic impact, for papers by Tamotsu Yokota Breakdown of academic impact, for papers by Bruno Poirier Breakdown of academic impact, for papers by Ruihai Zhou Breakdown of academic impact, for papers by Federico Biscetti Breakdown of academic impact, for papers by Xiaochen He Breakdown of academic impact, for papers by Jinchuan Yan Breakdown of academic impact, for papers by Hongyan Dai Breakdown of academic impact, for papers by Emilie Distel
Rankless by CCL
2026